Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04525131
Title Safety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors CicloMed LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.